IRIS
FERRAU', Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.001
EU - Europa 1.815
AS - Asia 821
AF - Africa 2
SA - Sud America 2
OC - Oceania 1
Totale 4.642
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.993
IE - Irlanda 585
SE - Svezia 485
CN - Cina 450
SG - Singapore 297
IT - Italia 281
PL - Polonia 135
GB - Regno Unito 88
DE - Germania 66
FI - Finlandia 52
IN - India 39
UA - Ucraina 28
BE - Belgio 26
FR - Francia 25
VN - Vietnam 14
CZ - Repubblica Ceca 12
ID - Indonesia 12
AT - Austria 11
RU - Federazione Russa 6
CA - Canada 5
NL - Olanda 4
JP - Giappone 2
LT - Lituania 2
MX - Messico 2
NG - Nigeria 2
SA - Arabia Saudita 2
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
CH - Svizzera 1
CL - Cile 1
EE - Estonia 1
ES - Italia 1
GR - Grecia 1
HR - Croazia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MY - Malesia 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
TR - Turchia 1
Totale 4.642
Salva come PNG Salva come JPEG
Città #
Dublin 584
Chandler 492
Nyköping 303
Singapore 254
Beijing 181
Ashburn 144
Warsaw 134
Jacksonville 123
Messina 119
Princeton 102
Medford 94
Dearborn 77
Ann Arbor 76
Des Moines 71
Cambridge 65
Lancaster 54
New York 40
Shenyang 40
Jinan 34
Boardman 29
Wilmington 26
Brussels 25
Hyderabad 25
Los Angeles 24
Munich 24
Helsinki 23
Nanjing 22
Tianjin 21
Guangzhou 18
San Mateo 17
Seattle 17
Catania 14
Dong Ket 14
Houston 14
Pune 14
Zhengzhou 14
Bremen 12
Hangzhou 12
Jakarta 12
Nanchang 12
Ningbo 11
Vienna 11
Haikou 10
Taizhou 10
Woodbridge 10
Hebei 8
Brno 7
Fairfield 7
Fuzhou 7
Milan 7
Norwalk 7
Fort Worth 6
London 6
Jiaxing 5
Aci Catena 4
Changsha 4
Lanzhou 4
Ottawa 4
Roccalumera 4
Rome 4
Turin 4
Vittoria 4
Clearwater 3
Genova 3
Lappeenranta 3
Naples 3
Olomouc 3
Oxford 3
Prineville 3
Ragusa 3
Augusta 2
Baotou 2
Bari 2
Brooklyn 2
Cardiff 2
Carrara 2
Caserta 2
Cisano Bergamasco 2
Cividale del Friuli 2
Dachau 2
Empoli 2
Floridia 2
Frankfurt am Main 2
Lagos 2
Livorno 2
Padova 2
Palermo 2
Pontedera 2
Redwood City 2
Reggio Calabria 2
Riyadh 2
San Mauro Marchesato 2
Shanghai 2
Tokyo 2
Trecastagni 2
Tuxtla Gutiérrez 2
Verolanuova 2
Amsterdam 1
Baku 1
Baoding 1
Totale 3.601
Salva come PNG Salva come JPEG
Nome #
Clinical management of critically ill patients with Cushing's disease due to ACTH-secreting pituitary macroadenomas: effectiveness of presurgical treatment with pasireotide 106
Diabetes secondary to acromegaly: Physiopathology, clinical features and effects of treatment 100
Acromegaly is more severe in patients with AHR or AIP gene variants living in highly polluted areas 95
Aggressive pituitary adenomas: the dark side of the moon 91
Cyberknife stereotactic treatment of pituitary adenomas: A single center experience using different irradiation schemes and modalities 88
Aggiornamento sulla chirurgia ipofisaria per via endoscopica: indicazioni, vantaggi e limiti 84
GSTP1 gene methylation and AHR rs2066853 variant predict resistance to first generation somatostatin analogs in patients with acromegaly 78
Course of Pregnancy in Cushing Disease under Different Management Approaches (No Treatment, Surgery, Gamma-Knife or Ketoconazole) 77
PRIMARY EMPTY SELLA IS ASSOCIATED WITH INCREASED CARDIOVASCULAR RISK, REGARDLESS THE OCCURRENCE OF PITUITARY DYSFUNCTION 75
P-57 Increased prevalence of acromegaly in an industrialized area of north-east of Sicily: a case-control study 75
Peptide receptor radionuclide therapy with 111IN-DTPA-Octreotide in a woman with Cabergoline-resistant giant prolactinoma 74
Increased prevalence of acromegaly in a highly polluted area. 73
Multidisciplinary management of pituitary apoplexy 71
Resistance to somatostatin analogues is associated with GSTP1 gene methylation and AHR rs2066853 variant in acromegaly patients 68
Epidemiologia degli adenomi ipofisari nel nord-est della Sicilia 67
Effectiveness and safety of long-term pegvisomant administration in patients with acromegaly not controlled by other therapies: experience of an Italian center. 67
Increased prevalence of restless legs syndrome in patients with acromegaly and effects on quality of life assessed by Acro-QoL. 66
Increased serum interleukin-22 levels in patients with PRL-secreting and non-functioning pituitary macroadenomas. 66
Cardiovascular events in acromegaly: distinct role of Agatston and Framingham score in the 5-year prediction. 66
Thyroid nodules in growth hormone replaced patients. 66
First report on persistent remission of acromegaly after withdrawal of long-term pegvisomant monotherapy 65
Acromegaly, genetic variants of the aryl hydrocarbon receptor pathway and environmental burden 64
Temozolomide-induced shrinkage of a pituitary carcinoma causing Cushing's disease--report of a case and literature review. 63
Effects of pasireotide treatment on cardio-metabolic risk in patients with Cushing's disease: an Italian, multicenter study 63
Peptide receptor radionuclide therapy for aggressive pituitary tumors: a monocentric experience 63
Increased frequency of the rs2066853 variant of aryl hydrocarbon receptor gene in patients with acromegaly 61
Global epidemiology of acromegaly: A systematic review and meta-analysis 61
First demonstration of the effectiveness of peptide receptor radionuclide therapy (PRRT) with 111In-DTPA-octreotide in a giant PRL-secreting pituitary adenoma resistant to conventional treatment. 58
An extremely rare association of TSH-secreting pituitary adenoma, metastatic neuroendocrine tumor and Cushing’s syndrome in a patient with MEN-1 gene mutation 58
Effects of cyberknife radiotherapy treatment of pituitary adenomas 57
Health-related quality of life in patients with Cushing's syndrome 57
Biochemical control and clinical improvement is induced by long-term pasireotide administration in the majority of patients with Cushing[apos]s disease persistent after pituitary surgery 57
Pitfalls in the 2017 TNM Classification of Thyroid Carcinoma 56
High bone marrow fat in patients with Cushing’s syndrome and vertebral fractures 55
Analysis of GPR101 and AIP genes mutations in acromegaly: a multicentric study 54
Visceral adiposity index as an indicator of cardiometabolic risk in patients treated for craniopharyngioma 53
Comment to ‘glucocorticoid resistance syndrome caused by a novel nr3c1 point mutation’ by al argan et al. 53
Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective 52
Temozolomide-induced shrinkage of a pituitary carcinoma. 51
Pasireotide treatment reduces cardiometabolic risk in Cushing's disease patients: an Italian, multicenter study 51
From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell? 51
Increased serum brain natriuretic peptide levels are a major predictor of myocardial hypertrophy in acromegalic patients. 50
Course of pregnancies in women with Cushing's disease treated by gamma-knife 49
Adrenal cancer in neurofibromatosis type 1: case report and DNA analysis 49
An unusual case of idiopathic hyperprolactinemia 49
Cardiometabolic Risk in Acromegaly: A Review With a Focus on Pasireotide 49
Global Cushing's disease epidemiology: a systematic review and meta-analysis of observational studies 49
Absence of GNAS1 mutations in somatotropinomas from AIPmut positive patients: possible implications for phenotype. 48
Increased interleukin 22 circulating levels in patients with tumors involving the hypothalamic-pituitary region 48
Peptide receptor radionuclide therapy (PRRT) in patients with giant aggressive pituitary tumors: experience of an Italian referral center and review of literature 48
Establishment of a protocol to extend the lifespan of human hormone-secreting pituitary adenoma cells 48
The ubiquitin-specific peptidase 8 (USP8) gene is frequently mutated in adenomas causing Cushing's disease 46
Pregnancy after azathioprine therapy for ulcerative colitis in a woman with autoimmune premature ovarian failure and Addison's disease: HLA haplotype characterization. 45
Adrenocorticotropin responsiveness to acute octreotide administration is not affected by mifepristone premedication in patients with Cushing's disease. 45
X-linked acrogigantism: a new condition of growth hormone excess. 42
Immunohistochemical localization and functional characterization of somatostatin receptor subtypes in a corticotropin releasing hormone-secreting adrenal phaeochromocytoma: review of the literature and report of a case 41
Landscape of familial isolated and young-onset pituitary adenomas: Prospective diagnosis in AIP mutation carriers 40
Endocrinologia & Malattie del Metabolismo 40
Neoadjuvant Therapy for Neuroendocrine Neoplasms: Recent Progresses and Future Approaches 40
Cabergoline-related impulse control disorder in an adolescent with a giant prolactinoma 39
Sindromi ipercalcemiche 39
What factors have impact on glucocorticoid replacement in adrenal insufficiency: a real-life study 38
Sequence analysis of the catalytic subunit of PKA in somatotroph adenomas 37
Systemic comorbidities induce early vascular alterations in patients with active acromegaly. 36
Paradoxical GH increase during OGTT is associated to first-generation somatostatin analogs responsiveness in acromegaly 35
MicroRNAs expression in pituitary tumors: differences related to functional status, pathological features, and clinical behavior 35
Oral mucositis induced by treatment with soft gel formulation of levothyroxine 34
L'acromegalia 34
Clinical Consequences of Variable Results in the Measurement of Free Thyroid Hormones: Unusual Presentation of a Family with a Novel Variant in the THRB Gene Causing Resistance to Thyroid Hormone Syndrome 34
Metabolic syndrome in cushing's syndrome patients 33
The man with acromegaly who inspired the Shrek animated project. 33
Methylome Analysis in Nonfunctioning and GH-Secreting Pituitary Adenomas 32
How to diagnose and manage Cushing's disease during pregnancy, when hypercortisolism is mild? 32
An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis 32
Metabolic comorbidities in Cushing's syndrome 32
What we have to know about corticosteroids use during Sars-Cov-2 infection 32
Somatic Deletion in Exon 10 of Aryl Hydrocarbon Receptor Gene in Human GH-Secreting Pituitary Tumors 32
Long-term cardiometabolic outcome in patients with pituitary adenoma diagnosed in chilhood and adolescence 32
Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies 32
Role of pituitary dysfunction on cardiovascular risk in primary empty sella patients 31
Tertiary hypercortisolism due to occult Cushing's syndrome 31
GPR101 variants in acromegaly: results from a large series of patients. 29
Unique clinical picture in patients with X-linked acrogigantism 28
Effects Of Epigenetic Changes In Gstp1 And Mgmt Gene On Clinicopathological Fatures Of Acromegaly Patients 28
Shrinkage of a pituitary metastasis of melanoma induced by pembrolizumab: a case report 28
The Enhanced Proteasomal Degradation of AIP Mutant Proteins Is a Mechanism for AIP Deficiency in AIP mutation-Associated Pituitary Adenomas 27
null 27
Emerging multitarget tyrosine kinase inhibitors in the treatment of neuroendocrine neoplasms 27
Pituitary Adenomas Harboring AIP Mutations Exhibit Phenotype-Genotype Correlation, but No Association with the Germline FGFR4 G388R Variant or Somatic GNAS1 Mutations 26
Gastroenteropancreatic neuroendocrine neoplasms and inflammation: A complex cross-talk with relevant clinical implications 25
A New Clinical Model to Estimate the Pre-Test Probability of Cushing’s Syndrome: The Cushing Score 25
Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study 24
Epidemiology, course, and outcomes of Sars-CoV-2 infection in patients with acromegaly and Cushing’s disease: a monocentric experience in Southern Italy 23
Somatic USP8 mutations are frequent events in corticotroph tumor progression causing Nelson's tumor 23
The gene of the ubiquitin-specific protease 8 is frequently mutated in adenomas causing cushing's disease 23
Somatic mutations in USP8 are frequent events in pituitary tumors causing Nelson's syndrome 22
Environmental Endocrinology and Endocrine Disruptors: Environmental Impact on the Hypothalamus–Pituitary Axis 21
Polymorphism or mutation? - The role of the R304Q missense AIP mutation in the predisposition to pituitary adenoma 20
Genetic and epigenetic modulation of AHR pathway in GH-secreting pituitary tumors and effects on acromegaly clinical phenotype 19
Persistent severe visual field impairment is associated with obesity and tumour invasiveness, but not with pituitary dysfunction, in patients with craniopharyngioma 18
Totale 4.790
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.615
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.615
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020380 0 0 0 0 0 86 33 29 19 142 60 11
2020/2021619 24 22 190 31 88 83 34 35 44 34 11 23
2021/2022662 1 69 12 30 18 10 27 23 10 97 120 245
2022/20231.733 164 180 78 136 115 158 36 91 691 14 43 27
2023/2024456 32 76 22 42 39 103 6 46 2 29 4 55
2024/2025579 55 36 71 169 171 77 0 0 0 0 0 0
Totale 4.936